<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-title>PLoS ONE</journal-title><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">07-PONE-RA-01077R1</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0001090</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Genetics and Genomics/Medical Genetics</subject><subject>Diabetes and Endocrinology/Type 2 Diabetes</subject></subj-group></article-categories><title-group><article-title>Variants in the <italic>FFAR1</italic> Gene Are Associated with Beta Cell Function</article-title><alt-title alt-title-type="running-head">FFAR1 and Beta Cell Function</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kalis</surname><given-names>Martins</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lev&#x000e9;en</surname><given-names>Per</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lyssenko</surname><given-names>Valeriya</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Almgren</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Groop</surname><given-names>Leif</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Cilio</surname><given-names>Corrado M.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Department of Clinical Sciences, Cellular Autoimmunity Unit, Lund University, Malm&#x000f6; University Hospital, Malm&#x000f6;, Sweden</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Department of Clinical Sciences, Diabetes and Endocrinology, Lund University, Malm&#x000f6; University Hospital, Malm&#x000f6;, Sweden</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Maedler</surname><given-names>Kathrin</given-names></name><role>Academic Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">University of California at Los Angeles, United States of America</aff><author-notes><corresp id="cor1">&#x0002a; To whom correspondence should be addressed. E-mail: <email>corrado.cilio@med.lu.se</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: LG CC MK PL. Performed the experiments: MK PL. Analyzed the data: VL PA MK. Contributed reagents/materials/analysis tools: LG CC. Wrote the paper: LG CC MK PL.</p></fn></author-notes><pub-date pub-type="collection"><year>2007</year></pub-date><pub-date pub-type="epub"><day>7</day><month>11</month><year>2007</year></pub-date><volume>2</volume><issue>11</issue><elocation-id>e1090</elocation-id><history><date date-type="received"><day>12</day><month>4</month><year>2007</year></date><date date-type="accepted"><day>8</day><month>10</month><year>2007</year></date></history><copyright-statement>Kalis et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement><copyright-year>2007</copyright-year><abstract><sec><title>Background</title><p>The FFAR1 receptor is expressed mainly in pancreatic beta cells and is activated by medium to long chain free fatty acids (FFAs), as well as by thiazolidinediones, resulting in elevated Ca<sup>2&#x0002b;</sup> concentrations and promotion of insulin secretion. These properties suggest that FFAR1 could be a mediator of lipotoxicity and a potential candidate gene for Type 2 diabetes (T2D). We therefore investigated whether variations at the <italic>FFAR1</italic> locus are associated with T2D and beta cell function.</p></sec><sec><title>Methodology/Principal Findings</title><p>We re-sequenced the <italic>FFAR1</italic> region in 96 subjects (48 healthy and 48 T2D individuals) and found 13 single nucleotide polymorphisms (SNPs) 8 of which were not previously described. Two SNPs located in the upstream region of the <italic>FFAR1</italic> gene (rs1978013 and rs1978014) were chosen and genotyped in 1929 patients with T2D and 1405 healthy control subjects. We observed an association of rs1978013 and rs1978014 with insulinogenic index in males (p&#x0200a;&#x0003d;&#x0200a;0.024) and females (p&#x0200a;&#x0003d;&#x0200a;0.032), respectively. After Bonferroni corrections, no association with T2D was found in the case-control material, however a haplotype consisting of the T-G alleles conferred protection against T2D (p&#x0200a;&#x0003d;&#x0200a;0.0010).</p></sec><sec><title>Conclusions/Significance</title><p>Variation in the <italic>FFAR1</italic> gene may contribute to impaired beta cell function in T2D.</p></sec></abstract><counts><page-count count="6"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Deterioration of beta cell function is a hallmark of Type 2 diabetes (T2D) and is considered to contribute to worsening of glucose tolerance with time <xref ref-type="bibr" rid="pone.0001090-Groop1">&#x0005b;1&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0001090-Ahren1">&#x0005b;4&#x0005d;</xref>. While the underlying causes are not fully understood, chronic exposure of beta cells to high concentrations of glucose (glucotoxicity) and free fatty acids (FFAs) (lipotoxicicity) have been suggested to induce irreversible changes in islet function <xref ref-type="bibr" rid="pone.0001090-Manco1">&#x0005b;5&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0001090-Robertson1">&#x0005b;7&#x0005d;</xref>. The pathways by which glucose enters into beta cells are well described but less is known by which mechanisms elevated FFAs might affect beta cells and their function.</p><p>The free fatty acid receptor FFAR1 (GPR40&#x02013;G protein-coupled receptor 40) is the first gene product identified to act as an extracellular membrane receptor for FFAs. It was recently shown to be activated in pancreatic beta cells <italic>in vitro</italic> by medium to long chain free fatty acids (FFAs) <xref ref-type="bibr" rid="pone.0001090-Itoh1">&#x0005b;8&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0001090-Briscoe1">&#x0005b;10&#x0005d;</xref> as well as by thiazolidinediones (Rosiglitazone and MCC-555) <xref ref-type="bibr" rid="pone.0001090-Kotarsky1">&#x0005b;9&#x0005d;</xref>, causing elevated Ca<sup>2&#x0002b;</sup> concentrations and subsequent promotion of insulin secretion. <italic>FFAR1</italic> is located in the 19q13.1 chromosomal region, which has been linked to T2D <xref ref-type="bibr" rid="pone.0001090-2">&#x0005b;11&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001090-Mori1">&#x0005b;12&#x0005d;</xref> and T2D-related phenotypes <xref ref-type="bibr" rid="pone.0001090-Ahren1">&#x0005b;4&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001090-Panhuysen1">&#x0005b;13&#x0005d;</xref> in several genome wide scans. The open reading frame of the gene encompasses a single exon of 903 bp encoding seven transmembrane domains, characteristic of G protein-coupled receptors (GPCRs) <xref ref-type="bibr" rid="pone.0001090-Sawzdargo1">&#x0005b;14&#x0005d;</xref>. Studies in rodents and humans have shown that the FFAR1 is expressed mainly in pancreatic beta cells, but also in the brain <xref ref-type="bibr" rid="pone.0001090-Itoh1">&#x0005b;8&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0001090-Briscoe1">&#x0005b;10&#x0005d;</xref>. Mice with overexpression of FFAR1 show impaired beta cell function and develop diabetes, whereas disruption of the gene reduces FFA-stimulated insulin release <xref ref-type="bibr" rid="pone.0001090-Latour1">&#x0005b;15&#x0005d;</xref> and, according to Steneberg et al., protects from diabetes <xref ref-type="bibr" rid="pone.0001090-Steneberg1">&#x0005b;16&#x0005d;</xref>. These properties make FFAR1 an interesting candidate for mediating lipotoxicity in beta cells although its role in this process is not fully unravelled. To investigate whether variation in the <italic>FFAR1</italic> locus is associated with human T2D, we re-sequenced the <italic>FFAR1</italic> gene and tested two of the identified SNPs for association with T2D and beta cell function.</p></sec><sec sec-type="materials|methods" id="s2"><title>Materials and Methods</title><sec id="s2a"><title>Study subjects</title><p>To identify SNPs in the <italic>FFAR1</italic> region, 48 T2D patients (31 male, 17 females, age 51&#x000b1;6, BMI 25.4&#x000b1;1.7) and 48 healthy glucose-tolerant control subjects (20 males, 28 females, age 62&#x000b1;7, BMI 23.2&#x000b1;2.1) from the Botnia study <xref ref-type="bibr" rid="pone.0001090-Groop2">&#x0005b;17&#x0005d;</xref> were selected for initial sequence analysis.</p><p>The case-control material genotyped consisted of 1929 patients with T2D and 1405 control subjects from Finland and Sweden (<xref ref-type="table" rid="pone-0001090-t001">Table 1</xref>). In addition, we studied whether SNPs in the <italic>FFAR1</italic> gene influenced insulin secretion and FFA levels measured during oral glucose tolerance test (OGTT) in 1011 non-diabetic individuals participating in the Botnia study (<xref ref-type="table" rid="pone-0001090-t001">Table 1</xref>) <xref ref-type="bibr" rid="pone.0001090-Groop2">&#x0005b;17&#x0005d;</xref>. Study subjects were unrelated except 354 sibling pairs (each pair from different family) included in the cohort of 1011 healthy individuals.</p><table-wrap id="pone-0001090-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0001090.t001</object-id><label>Table 1</label><caption><title>Clinical characteristics of patient samples</title></caption><graphic id="pone-0001090-t001-1" xlink:href="pone.0001090.t001"/><table frame="hsides" rules="groups" alternate-form-of="pone-0001090-t001-1"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td colspan="2" align="left" rowspan="1">Association study</td><td align="left" rowspan="1" colspan="1">Healthy Botnia individuals</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">T2D</td><td align="left" rowspan="1" colspan="1">CONTROLS</td><td align="left" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><italic>n</italic></td><td align="left" rowspan="1" colspan="1">1929<xref ref-type="table-fn" rid="nt102">&#x0002a;</xref></td><td align="left" rowspan="1" colspan="1">1405<xref ref-type="table-fn" rid="nt103">&#x0002a;&#x0002a;</xref></td><td align="left" rowspan="1" colspan="1">1011</td></tr><tr><td align="left" rowspan="1" colspan="1">Sex (males/females)</td><td align="left" rowspan="1" colspan="1">1086/843</td><td align="left" rowspan="1" colspan="1">652/753</td><td align="left" rowspan="1" colspan="1">475/536</td></tr><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="left" rowspan="1" colspan="1">61.6&#x000b1;11.5</td><td align="left" rowspan="1" colspan="1">52.8&#x000b1;13.6</td><td align="left" rowspan="1" colspan="1">50&#x000b1;15</td></tr><tr><td align="left" rowspan="1" colspan="1">Age of onset of T2D (years)</td><td align="left" rowspan="1" colspan="1">56.7&#x000b1;11.4</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td align="left" rowspan="1" colspan="1">29.58&#x000b1;5.33</td><td align="left" rowspan="1" colspan="1">25.92&#x000b1;3.78</td><td align="left" rowspan="1" colspan="1">26.8&#x000b1;4.2</td></tr><tr><td align="left" rowspan="1" colspan="1">Fasting plasma glucose (mmol/l)</td><td align="left" rowspan="1" colspan="1">11.36&#x000b1;4.19</td><td align="left" rowspan="1" colspan="1">5.38&#x000b1;0.44</td><td align="left" rowspan="1" colspan="1">5.59&#x000b1;0.58</td></tr><tr><td align="left" rowspan="1" colspan="1">2 hour plasma glucose (mmol/l)</td><td align="left" rowspan="1" colspan="1">15.54&#x000b1;5.7</td><td align="left" rowspan="1" colspan="1">5.67&#x000b1;1.10</td><td align="left" rowspan="1" colspan="1">6.47&#x000b1;1.63</td></tr><tr><td align="left" rowspan="1" colspan="1">C-peptide (nmol/l)</td><td align="left" rowspan="1" colspan="1">1.03&#x000b1;0.55</td><td align="left" rowspan="1" colspan="1">ND</td><td align="left" rowspan="1" colspan="1">ND</td></tr><tr><td align="left" rowspan="1" colspan="1">Fasting plasma insulin (pmol/l)</td><td align="left" rowspan="1" colspan="1">69.32&#x000b1;61.01</td><td align="left" rowspan="1" colspan="1">40.79&#x000b1;24.27</td><td align="left" rowspan="1" colspan="1">50.95&#x000b1;29.95</td></tr><tr><td align="left" rowspan="1" colspan="1">2 hour insulin (pmol/l)</td><td align="left" rowspan="1" colspan="1">354.45&#x000b1;323.46</td><td align="left" rowspan="1" colspan="1">205.85&#x000b1;165.44</td><td align="left" rowspan="1" colspan="1">300.22&#x000b1;262.66</td></tr><tr><td align="left" rowspan="1" colspan="1">HOMA</td><td align="left" rowspan="1" colspan="1">5.80&#x000b1;8.51</td><td align="left" rowspan="1" colspan="1">1.58&#x000b1;0.97</td><td align="left" rowspan="1" colspan="1">2.15&#x000b1;1.38</td></tr><tr><td align="left" rowspan="1" colspan="1">Insulinogenic index</td><td align="left" rowspan="1" colspan="1">2.84&#x000b1;3.77</td><td align="left" rowspan="1" colspan="1">5.86&#x000b1;4.17</td><td align="left" rowspan="1" colspan="1">5.84&#x000b1;3.98</td></tr><tr><td align="left" rowspan="1" colspan="1">HbA<sub>1c</sub> (&#x00025;)</td><td align="left" rowspan="1" colspan="1">7.73&#x000b1;2</td><td align="left" rowspan="1" colspan="1">5.19&#x000b1;0.5</td><td align="left" rowspan="1" colspan="1">5.44&#x000b1;0.49</td></tr><tr><td align="left" rowspan="1" colspan="1">Triglicerides (mmol/l)</td><td align="left" rowspan="1" colspan="1">2.4&#x000b1;2.27</td><td align="left" rowspan="1" colspan="1">1.29&#x000b1;0.76</td><td align="left" rowspan="1" colspan="1">1.38&#x000b1;0.89</td></tr><tr><td align="left" rowspan="1" colspan="1">Cholesterol (mmol/l)</td><td align="left" rowspan="1" colspan="1">5.58&#x000b1;1.29</td><td align="left" rowspan="1" colspan="1">5.83&#x000b1;1.18</td><td align="left" rowspan="1" colspan="1">5.67&#x000b1;1.12</td></tr><tr><td align="left" rowspan="1" colspan="1">HDL cholesterol (mmol/l)</td><td align="left" rowspan="1" colspan="1">1.16&#x000b1;0.32</td><td align="left" rowspan="1" colspan="1">1.37&#x000b1;0.41</td><td align="left" rowspan="1" colspan="1">1.37&#x000b1;0.34</td></tr><tr><td align="left" rowspan="1" colspan="1">Systolic blood pressure (mmHg)</td><td align="left" rowspan="1" colspan="1">144.55&#x000b1;22.05</td><td align="left" rowspan="1" colspan="1">133.48&#x000b1;19.22</td><td align="left" rowspan="1" colspan="1">132.78&#x000b1;19.74</td></tr><tr><td align="left" rowspan="1" colspan="1">Diastolic blood pressure (mmHg)</td><td align="left" rowspan="1" colspan="1">81.06&#x000b1;10.87</td><td align="left" rowspan="1" colspan="1">81.21&#x000b1;10.57</td><td align="left" rowspan="1" colspan="1">80.51&#x000b1;10.27</td></tr></tbody></table><table-wrap-foot><fn id="nt101"><p>Legend to <xref ref-type="table" rid="pone-0001090-t001">Table 1</xref>. Data are mean&#x000b1;SD. ND: not determined.</p></fn><fn id="nt102"><label>&#x0002a;</label><p>1455 T2D patients were measured for C peptide but the rest 451&#x02013;for fasting plasma insulin (HOMA index was calculated from these). Values of 2 hrs glucose and insulin were obtained for 256 and 251 individual, respectively. Insulinogenic index could be calculated for 192 T2D patients. Blood pressure information was obtained from 1438 patients.</p></fn><fn id="nt103"><label>&#x0002a;&#x0002a;</label><p>Values of 2 hrs glucose and insulin, HOMA, insulinogenic index and HDL cholesterol were available only in 68&#x00025; of the control group but trigliceride values in 87&#x00025; of the individuals.</p></fn></table-wrap-foot></table-wrap><p>Diagnosis of T2D was based according to WHO criteria <xref ref-type="bibr" rid="pone.0001090-Alberti1">&#x0005b;18&#x0005d;</xref>, GADA negative status and age at onset &#x0003e;35 years (except for three individuals which were below 35 years). Weight, height, plasma glucose, plasma insulin, triglicerides, total cholesterol, HDL cholesterol and blood pressure were measured and oral glucose tolerance test (OGTT) performed as described by Groop et al. <xref ref-type="bibr" rid="pone.0001090-Groop2">&#x0005b;17&#x0005d;</xref>; plasma FFA levels were determined using an enzymatic colorimetric method (NEFAC ACS-ACOD Method, Wako Chemicals, Richmond, VA). Haemoglobin A<sub>1c</sub> (HbA1c) was measured by high-pressure liquid chromatography with a normal range of 4&#x02013;6&#x00025; (Diamat Analyzer, Biorad Laboratories, Germany). Body mass index (BMI) was calculated as weight (in kilograms) divided by height (in meters) squared. Insulinogenic index (&#x00394; Insulin <sub>30 min-fasting</sub>/Glucose <sub>30 min</sub>) and homeostasis model assessment index (HOMA) <xref ref-type="bibr" rid="pone.0001090-Matthews1">&#x0005b;19&#x0005d;</xref> was used to describe insulin secretion and insulin resistance, respectively. All subjects gave their informed consent at the time of entering to the study, which was approved by local ethics committees at Helsinki and Lund Universities.</p></sec><sec id="s2b"><title>Sequencing of <italic>FFAR1</italic></title><p>A 2379 bp long DNA including the 903 bp of the coding region in the <italic>FFAR1</italic> gene was re-sequenced. Reference sequence was taken from the NCBI database (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov">http://www.ncbi.nlm.nih.gov</ext-link>)<xref ref-type="bibr" rid="pone.0001090-National1">&#x0005b;20&#x0005d;</xref>. In order to sequence the <italic>FFAR1</italic> region, four primer pairs of overlapping PCR products were designed using program Primer Premier 5.0 (Premier Biosoft International). Standard protocols for PCR were as follows (5&#x02032;-3&#x02032; sequences of forward and reverse primers, product size, annealing temperature): 1) <named-content content-type="gene">CTCCCCTTCCGGCTCACT</named-content>, <named-content content-type="gene">CTCTCCACCATGTCACCTCTTA</named-content>, 566 bp, 50&#x000b0;C; 2) <named-content content-type="gene">CAGGAGTCAAACTCCCATTCC</named-content>, <named-content content-type="gene">AGGTGTTGCTGTGGTCCAG</named-content>, 901 bp, 62&#x000b0;C (designed by MRC Geneservice, Cambridge, UK); 3) <named-content content-type="gene">TTGGGCTACCAAGCCTTC</named-content>, <named-content content-type="gene">CTGCAGTTCCTCCGAAGC</named-content>, 658 bp, 60&#x000b0;C; 4) <named-content content-type="gene">GTGACCGGTTACTTGGGAAG</named-content>, <named-content content-type="gene">CTTTGGGGGAGTCAAAGTCAT</named-content>, 752 bp, 62&#x000b0;C. PCR reactions were performed on GeneAmp PCR System 9700 (Perkin Elmer).</p><p>Sequencing reactions were performed using BigDye v3.1 kit (Applied Biosystems) on GeneAmp PCR System 9700 according to manufacturers protocol. Sequencing products were purified with DyeEx 96 kit (QIAGEN) and run on ABI Prism 3730 Genetic Analyzer (Applied Biosystems). Sequencing data were analyzed with program Sequencher 3.1.2 (Gene Codes Corporation, Ann Arbor, MI, USA).</p><p>Selected SNPs were genotyped using the SNaPshot assay on an ABI 3100 DNA sequencer (Applied Biosystems) according to the manufacturer&#x02032;s protocol.</p></sec><sec id="s2c"><title>Genotyping</title><p>PCR fragment for the multiplex SNP genotyping of FFAR1 polymorphisms rs1978013 and rs1978014 with SNaPshot assay was amplified in 20 &#x000b5;l reaction volume at an annealing temperature of 55&#x000b0;C, primers (5&#x02032;-3&#x02032;): <named-content content-type="gene">CTCCCCTTCCGGCTCACT</named-content> and <named-content content-type="gene">CTCTCCACCATGTCACCTCTTA</named-content>. PCR products were treated with Shrimp Alkaline Phosphatase (SAP) (USB Corporation) and Exonuclease I (New England Biolabs). Extension primer sequence (5&#x02032;-3&#x02032;) for rs1978013 was <named-content content-type="gene">ACCGTGACATGGATGGGGCC</named-content> and for rs1978014&#x02013;<underline>AACTG</underline>GGGAGAGCCCAAGGGTCAGC, where the underlined nucleotides indicate an unspecific primer tail included in order to produce differently sized products. The minisequencing reaction was performed on GeneAmp PCR System 9700 according to manufacturer's protocol. After SAP/Exonuclease I treatment, samples where run on ABI Prism 3100 Genetic Analyzer and data analyzed using the GeneMapper 3.1 software (Applied Biosystems).</p></sec><sec id="s2d"><title>Statistical and bioinformatic analysis</title><p>Linkage disequilibrium (LD) calculations and haplotype analysis were carried out using Haploview 3.32 software (<ext-link ext-link-type="uri" xlink:href="http://www.broad.mit.edu/mpg/haploview/">http://www.broad.mit.edu/mpg/haploview/</ext-link>)<xref ref-type="bibr" rid="pone.0001090-Daly1">&#x0005b;21&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001090-Barrett1">&#x0005b;22&#x0005d;</xref>. For haplotype reconstruction and subsequent analysis of metabolic parameters, we used HAP haplotype analysis system available online at <ext-link ext-link-type="uri" xlink:href="http://research.calit2.net/hap">http://research.calit2.net/hap</ext-link><xref ref-type="bibr" rid="pone.0001090-Eskin1">&#x0005b;23&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001090-Halperin1">&#x0005b;24&#x0005d;</xref>. Power calculations were performed online using Genetic Power Calculator (<ext-link ext-link-type="uri" xlink:href="http://ibgwww.colorado.edu/pshaun/gpc">http://ibgwww.colorado.edu/pshaun/gpc</ext-link>)<xref ref-type="bibr" rid="pone.0001090-Purcell1">&#x0005b;25&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001090-Purcell2">&#x0005b;26&#x0005d;</xref>. Chi-squared test was used to compare the general genotype frequency distribution among T2D and control groups. Odds ratios were calculated using logistic regression analysis with age, BMI and sex as covariates. Mantel-Haenszel test was used to test for heterogeneity between the Swedish and Finnish samples. Differences in insulinogenic index and FFA levels between different genotype carriers were assessed using either ANOVA (for equal weight of genotypes) or linear regression analysis with age, BMI and sex as covariates. A robust variance estimator was used to adjust for the possible non-independence due to family clustering. Correlation between insulin secretion and FFA levels was analysed using multivariate regression correlation matrix (NCSS software). The standard errors were adjusted for repeated measurements made on the same individual by methods of GEE methodology. A p value of &#x0003c;0.05 was considered statistically significant. Bonferroni adjustments for multiple measurements were done were appropriate: p-values were corrected by four in the case-control study (two SNPs tested, stratified by sex), by eight in the phenotype analysis (two SNPs tested for insulinogenic index and post-OGTT FFA levels, stratified by sex) and by eight in the phenotype analysis in haplotypes (four haplotypes tested for insulinogenic index and post-OGTT FFA levels). We chose the additive model as the main hypothesis because it is the model that corresponds better to the putative biological function of FFAR1 receptor <xref ref-type="bibr" rid="pone.0001090-Itoh2">&#x0005b;27&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0001090-Hawkins1">&#x0005b;29&#x0005d;</xref>. Therefore p values were not corrected for other genetic models explored (equal weight, recessive and dominant). To correct for multiple testing in the haplotype analysis, 10000 permutations were done using the Haploview software. The 5&#x02032; upstream region of the <italic>FFAR1</italic> gene was analysed for putative regulatory elements using the MatInspector program (<ext-link ext-link-type="uri" xlink:href="http://www.genomatix.de/products/MatInspector/">http://www.genomatix.de/products/MatInspector/</ext-link>) <xref ref-type="bibr" rid="pone.0001090-Genomatix1">&#x0005b;30&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001090-Cartharius1">&#x0005b;31&#x0005d;</xref>.</p></sec></sec><sec id="s3"><title>Results</title><p>We first re-sequenced a 2379 bp fragment of the <italic>FFAR1</italic> region in a screening panel of 96 subjects (48 T2D and 48 healthy subjects). We identified 13 SNPs and two of these polymorphisms where located in the coding region of the gene, including one synonymous (Val) and one non-synonymous (Arg/His, rs2301151) polymorphism. Five of the SNPs (rs1978013, rs1978014, rs10418569, rs2301151 and rs1573611) were previously registered in the NCBI database <xref ref-type="bibr" rid="pone.0001090-National1">&#x0005b;20&#x0005d;</xref>, whereas eight SNPs are new (<xref ref-type="supplementary-material" rid="pone.0001090.s001">Figure S1</xref>).</p><p>There was no clear linkage disequilibrium between the 13 SNPs (<xref ref-type="supplementary-material" rid="pone.0001090.s002">Figure S2</xref>). The minor allele frequencies (MAF) of the eight newly discovered SNPs were less then 0.02, the other five SNPs had MAF 0.10&#x02013;0.48.</p><p>Of them, only the frequencies of the two SNPs at positions 598 and 597 bp upstream of the open reading frame (rs1978013 and rs1978014; <xref ref-type="supplementary-material" rid="pone.0001090.s001">Figure S1</xref>) differed between the T2D and control subjects in the screening panel (rs1978013: 13 TT, 25 TC and 10 CC in T2D vs. 15 TT, 31 TC and 2 CC in controls, p&#x0200a;&#x0003d;&#x0200a;0.047 and for rs1978014: 4 AA, 4 AG and 9 GG in T2D patients with BMI&#x0003c;30 vs. 12 AA, 20 AG and 7 GG in control individuals with BMI&#x0003c;30, p&#x0200a;&#x0003d;&#x0200a;0.024). These two SNPs were then further tested for association with T2D in a case-control material from Finland and Sweden consisting of 1929 patients with T2D and 1405 control subjects. All genotypes were in Hardy-Weinberg equilibrium, both in cases and in controls.</p><p>The Tagger algorithm <xref ref-type="bibr" rid="pone.0001090-3">&#x0005b;32&#x0005d;</xref> of the Haploview software showed that with r<sup>2</sup> threshold of 0.3 rs1978013 captures rs10418569 (D' 0.94, r<sup>2</sup> 0.33) and rs1573611 (D' 0.89, r<sup>2</sup> 0.31), whereas rs1978014 captures rs10418569 (D' 1, r<sup>2</sup> 0.28) and rs2301151 (D' 1, r<sup>2</sup> 0.12) at r<sup>2</sup> threshold 0.1 (<xref ref-type="supplementary-material" rid="pone.0001090.s002">Figure S2</xref>).</p><p>The bioinformatic analysis revealed three potential transcription factor-binding sites in the vicinity of rs1978013 and rs1978014&#x02013;ATF6 (located &#x02212;16 to &#x02212;10 bp or &#x02212;17 to &#x02212;11 bp upstream of rs1978013 and rs1978014, respectively), INSM1 (&#x02212;11 to &#x02212;3 bp/&#x02212;12 to &#x02212;4 bp) and NF-kappaB (&#x0002b;24 to &#x0002b;33 bp/&#x0002b;23 to &#x0002b;32 bp downstream).</p><p>There was more than 80&#x00025; power assuming an additive model to detect an OR of 1.32 (p&#x0200a;&#x0003d;&#x0200a;0.05) in the case-control material. However, after Bonferroni correction, no odds ratio was significantly associated with T2D. SNP rs1978014 had an OR 1.26 (95&#x00025; CI 1.00&#x02013;1.61) for association with T2D (uncorrected p&#x0200a;&#x0003d;&#x0200a;0.049, corr. p&#x0200a;&#x0003d;&#x0200a;0.196, <xref ref-type="table" rid="pone-0001090-t002">Table 2</xref>), while CC genotype of rs1978013 was more frequent in T2D group only in males (T2D 17.9&#x00025;, controls 15.5&#x00025;, OR 1.49, 95&#x00025; CI 1.07&#x02013;2.07, uncorr. p&#x0200a;&#x0003d;&#x0200a;0.019, corr. p&#x0200a;&#x0003d;&#x0200a;0.076; <xref ref-type="supplementary-material" rid="pone.0001090.s003">Table S1</xref>).</p><table-wrap id="pone-0001090-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0001090.t002</object-id><label>Table 2</label><caption><title>Genotype frequencies and odds ratios of the rs1978013 and rs1978014</title></caption><graphic id="pone-0001090-t002-2" xlink:href="pone.0001090.t002"/><table frame="hsides" rules="groups" alternate-form-of="pone-0001090-t002-2"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Genotypes and alleles</td><td align="left" rowspan="1" colspan="1">T2D <italic>n</italic> (&#x00025;) (n&#x0200a;&#x0003d;&#x0200a;1929)</td><td align="left" rowspan="1" colspan="1">Controls <italic>n</italic> (&#x00025;) (n&#x0200a;&#x0003d;&#x0200a;1405)</td><td align="left" rowspan="1" colspan="1">P (&#x003c7;<sup>2</sup> test)</td><td align="left" rowspan="1" colspan="1">Additive model OR (95&#x00025; CI)</td><td align="left" rowspan="1" colspan="1">p</td><td align="left" rowspan="1" colspan="1">Dominant model OR (95&#x00025; CI)</td><td align="left" rowspan="1" colspan="1">p</td><td align="left" rowspan="1" colspan="1">Recessive model OR (95&#x00025; CI)</td><td align="left" rowspan="1" colspan="1">p</td></tr></thead><tbody><tr><td colspan="10" align="left" rowspan="1">rs1978013</td></tr><tr><td align="left" rowspan="1" colspan="1">TT</td><td align="left" rowspan="1" colspan="1">621 (32.2)</td><td align="left" rowspan="1" colspan="1">503 (35.8)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">TC</td><td align="left" rowspan="1" colspan="1">969 (50.2)</td><td align="left" rowspan="1" colspan="1">673 (47.9)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1.09 (0.90&#x02013;1.30)</td><td align="left" rowspan="1" colspan="1">0.317/NS</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">CC</td><td align="left" rowspan="1" colspan="1">339 (17.6)</td><td align="left" rowspan="1" colspan="1">229 (16.3)</td><td align="left" rowspan="1" colspan="1">0.09/0.36</td><td align="left" rowspan="1" colspan="1">1.24 (0.97&#x02013;1.58)</td><td align="left" rowspan="1" colspan="1">0.082/0.328</td><td align="left" rowspan="1" colspan="1">1.12 (0.94&#x02013;1.33)</td><td align="left" rowspan="1" colspan="1">0.185/0.74</td><td align="left" rowspan="1" colspan="1">1.18 (0.95&#x02013;1.47)</td><td align="left" rowspan="1" colspan="1">0.135/0.54</td></tr><tr><td align="left" rowspan="1" colspan="1">T</td><td align="left" rowspan="1" colspan="1">2211 (57.3)</td><td align="left" rowspan="1" colspan="1">1679 (59.8)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>C</bold></td><td align="left" rowspan="1" colspan="1">1647(42.7)</td><td align="left" rowspan="1" colspan="1">1131 (40.2)</td><td align="left" rowspan="1" colspan="1"><bold>0.046/</bold>0.184</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="10" align="left" rowspan="1">rs1978014</td></tr><tr><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">327 (17)</td><td align="left" rowspan="1" colspan="1">286 (20.4)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">AG</td><td align="left" rowspan="1" colspan="1">910 (47.3)</td><td align="left" rowspan="1" colspan="1">676 (48.1)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1.13 (0.94&#x02013;1.36)</td><td align="left" rowspan="1" colspan="1">0.204/0.816</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">686 (35.7)</td><td align="left" rowspan="1" colspan="1">443 (31.5)</td><td align="left" rowspan="1" colspan="1"><bold>0.01/0.04</bold></td><td align="left" rowspan="1" colspan="1">1.27 (1.00&#x02013;1.61)</td><td align="left" rowspan="1" colspan="1"><bold>0.049/</bold>0.196</td><td align="left" rowspan="1" colspan="1">1.18 (0.96&#x02013;1.46)</td><td align="left" rowspan="1" colspan="1">0.116/0.464</td><td align="left" rowspan="1" colspan="1">1.16 (0.98&#x02013;1.39)</td><td align="left" rowspan="1" colspan="1">0.085/0.34</td></tr><tr><td align="left" rowspan="1" colspan="1">G</td><td align="left" rowspan="1" colspan="1">1564 (40.7)</td><td align="left" rowspan="1" colspan="1">1248 (44.4)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>A</bold></td><td align="left" rowspan="1" colspan="1">2282 (59.3)</td><td align="left" rowspan="1" colspan="1">1562 (55.6)</td><td align="left" rowspan="1" colspan="1"><bold>0.002/0.008</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="nt104"><p>Legend to <xref ref-type="table" rid="pone-0001090-t002">Table 2</xref>. Logistic regression results are adjusted for age, sex, BMI and family dependence. Both nominal and the Bonferroni-corrected p-values are shown. NS: not significant.</p></fn></table-wrap-foot></table-wrap><p>Haplotype analysis revealed that a haplotype consisting of the T-G alleles (permutated p&#x0200a;&#x0003d;&#x0200a;0.001) of SNPs rs1978013 and rs1978014 conferred protection whereas the C-A haplotype conferred increased risk (permutated p&#x0200a;&#x0003d;&#x0200a;0.0486) of T2D (<xref ref-type="table" rid="pone-0001090-t003">Table 3</xref>).</p><p>Post-OGTT FFA concentration did not significantly differ between different genotype carriers after Bonferroni corrections (<xref ref-type="table" rid="pone-0001090-t004">Table 4</xref>, <xref ref-type="supplementary-material" rid="pone.0001090.s003">Table S2</xref>). Post-OGTT FFA concentration was lower in the CC/CT carriers (223&#x000b1;95 mmol/l) vs. the TT genotype (244&#x000b1;148 mmol/l) of rs1978013 (uncorr. p&#x0200a;&#x0003d;&#x0200a;0.010, corr. p&#x0200a;&#x0003d;&#x0200a;0.08, <xref ref-type="table" rid="pone-0001090-t004">Table 4</xref>). After stratification for sex, post-OGTT FFA levels of rs1978013 were lower in males (TT&#x0200a;&#x0003d;&#x0200a;268&#x000b1;189, TC&#x0200a;&#x0003d;&#x0200a;239&#x000b1;96, CC&#x0200a;&#x0003d;&#x0200a;215&#x000b1;102 mmol/l, uncorr. p&#x0200a;&#x0003d;&#x0200a;0.012, corr. p&#x0200a;&#x0003d;&#x0200a;0.096, <xref ref-type="supplementary-material" rid="pone.0001090.s004">Table S2</xref>). In addition, the T-G haplotype showed association with post-OGTT FFA levels which disappeared after Bonferroni correction (T-G 231&#x000b1;120 vs C-A 225&#x000b1;98, T-A 244&#x000b1;139, C-G 210&#x000b1;89 mmol/l, uncorr. p&#x0200a;&#x0003d;&#x0200a;0.021, corr. p&#x0200a;&#x0003d;&#x0200a;0.168, <xref ref-type="table" rid="pone-0001090-t005">Table 5</xref>).</p><p>The rs1978013 was associated with insulinogenic index only in males (TT&#x0200a;&#x0003d;&#x0200a;6.2&#x000b1;3.8, TC&#x0002b;CC&#x0200a;&#x0003d;&#x0200a;5.3&#x000b1;3.4, uncorr. p&#x0200a;&#x0003d;&#x0200a;0.003, corr. p&#x0200a;&#x0003d;&#x0200a;0.024) while rs1978014 was associated with insulinogenic index only in females (GG&#x0002b;AG&#x0200a;&#x0003d;&#x0200a;6.4&#x000b1;4.7, AA&#x0200a;&#x0003d;&#x0200a;5.2&#x000b1;2.9, uncorr. p&#x0200a;&#x0003d;&#x0200a;0.004, corr. p&#x0200a;&#x0003d;&#x0200a;0.032; <xref ref-type="supplementary-material" rid="pone.0001090.s004">Table S2</xref>). In the whole sample, insulinogenic index was associated neither with genotypes (<xref ref-type="table" rid="pone-0001090-t004">Table 4</xref>) nor haplotypes (<xref ref-type="table" rid="pone-0001090-t005">Table 5</xref>) after Bonferroni corrections were done. Insulin secretion was lower in C allele carriers of rs1978013 (TT&#x0200a;&#x0003d;&#x0200a;6.3&#x000b1;4.3, TC&#x0002b;CC&#x0200a;&#x0003d;&#x0200a;5.6&#x000b1;3.8, uncorr. p&#x0200a;&#x0003d;&#x0200a;0.010, corr. p&#x0200a;&#x0003d;&#x0200a;0.08) and for AA genotype in rs1978014 (GG&#x0002b;AG&#x0200a;&#x0003d;&#x0200a;6&#x000b1;4.2, AA&#x0200a;&#x0003d;&#x0200a;5.3&#x000b1;3.2, uncorr. p&#x0200a;&#x0003d;&#x0200a;0.030, corr. p&#x0200a;&#x0003d;&#x0200a;0.24) (<xref ref-type="table" rid="pone-0001090-t004">Table 4</xref>). The C-A haplotype had the lowest insulinogenic index (C-A 5.5&#x000b1;3.7 vs T-G 6.1&#x000b1;4.3, T-A 6&#x000b1;3.9, C-G 5.8&#x000b1;3.8, uncorr. p&#x0200a;&#x0003d;&#x0200a;0.008, corr. p&#x0200a;&#x0003d;&#x0200a;0.064, <xref ref-type="table" rid="pone-0001090-t005">Table 5</xref>).</p><table-wrap id="pone-0001090-t003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0001090.t003</object-id><label>Table 3</label><caption><title>Association of haplotypes with T2D</title></caption><graphic id="pone-0001090-t003-3" xlink:href="pone.0001090.t003"/><table frame="hsides" rules="groups" alternate-form-of="pone-0001090-t003-3"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td colspan="2" align="left" rowspan="1">Allele</td><td colspan="2" align="left" rowspan="1">Haplotype frequency</td><td align="left" rowspan="1" colspan="1">p value</td><td align="left" rowspan="1" colspan="1">permutation p value &#x0002a;</td></tr><tr><td align="left" rowspan="1" colspan="1">rs1978013</td><td align="left" rowspan="1" colspan="1">rs1978014</td><td align="left" rowspan="1" colspan="1">T2D (n&#x0200a;&#x0003d;&#x0200a;1929)</td><td align="left" rowspan="1" colspan="1">Controls (n&#x0200a;&#x0003d;&#x0200a;1405)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">T</td><td align="left" rowspan="1" colspan="1">G</td><td align="left" rowspan="1" colspan="1">0.24</td><td align="left" rowspan="1" colspan="1">0.28</td><td align="left" rowspan="1" colspan="1"><bold>0.0009</bold></td><td align="left" rowspan="1" colspan="1"><bold>0.0010</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">0.26</td><td align="left" rowspan="1" colspan="1">0.24</td><td align="left" rowspan="1" colspan="1"><bold>0.0244</bold></td><td align="left" rowspan="1" colspan="1"><bold>0.0486</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">T</td><td align="left" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">0.33</td><td align="left" rowspan="1" colspan="1">0.32</td><td align="left" rowspan="1" colspan="1">0.2537</td><td align="left" rowspan="1" colspan="1">0.5397</td></tr><tr><td align="left" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">G</td><td align="left" rowspan="1" colspan="1">0.17</td><td align="left" rowspan="1" colspan="1">0.17</td><td align="left" rowspan="1" colspan="1">0.8663</td><td align="left" rowspan="1" colspan="1">0.9973</td></tr></tbody></table><table-wrap-foot><fn id="nt105"><p>Legend to <xref ref-type="table" rid="pone-0001090-t003">Table 3</xref>. &#x0002a; To correct for multiple testing, 10000 permutations were done.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone-0001090-t004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0001090.t004</object-id><label>Table 4</label><caption><title>Insulinogenic index and post-OGTT FFA levels in different genotype carriers</title></caption><graphic id="pone-0001090-t004-4" xlink:href="pone.0001090.t004"/><table frame="hsides" rules="groups" alternate-form-of="pone-0001090-t004-4"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td colspan="3" align="left" rowspan="1">rs1978013</td><td align="left" rowspan="1" colspan="1">p</td><td colspan="3" align="left" rowspan="1">rs1978014</td><td align="left" rowspan="1" colspan="1">p</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">TT (n&#x0200a;&#x0003d;&#x0200a;327)</td><td align="left" rowspan="1" colspan="1">TC (n&#x0200a;&#x0003d;&#x0200a;503)</td><td align="left" rowspan="1" colspan="1">CC (n&#x0200a;&#x0003d;&#x0200a;181)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">GG (n&#x0200a;&#x0003d;&#x0200a;215)</td><td align="left" rowspan="1" colspan="1">AG (n&#x0200a;&#x0003d;&#x0200a;510)</td><td align="left" rowspan="1" colspan="1">AA (n&#x0200a;&#x0003d;&#x0200a;286)</td><td align="left" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td colspan="9" align="left" rowspan="1"><italic>Insulinogenic index</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">Equal weight</td><td align="left" rowspan="1" colspan="1">6.3&#x000b1;4.3</td><td align="left" rowspan="1" colspan="1">5.8&#x000b1;4</td><td align="left" rowspan="1" colspan="1">5.3&#x000b1;3.2</td><td align="left" rowspan="1" colspan="1"><bold>0.022</bold>/0.176</td><td align="left" rowspan="1" colspan="1">5.9&#x000b1;4</td><td align="left" rowspan="1" colspan="1">6.1&#x000b1;4.3</td><td align="left" rowspan="1" colspan="1">5.3&#x000b1;3.2</td><td align="left" rowspan="1" colspan="1"><bold>0.030</bold>/0.24</td></tr><tr><td align="left" rowspan="1" colspan="1">Dominant model</td><td align="left" rowspan="1" colspan="1">6.3&#x000b1;4.3</td><td colspan="2" align="center" rowspan="1">5.6&#x000b1;3.8</td><td align="left" rowspan="1" colspan="1"><bold>0.010</bold>&#x0002a;/0.08</td><td align="left" rowspan="1" colspan="1">5.9&#x000b1;4</td><td colspan="2" align="center" rowspan="1">5.8&#x000b1;4</td><td align="left" rowspan="1" colspan="1">0.892&#x0002a;/NS</td></tr><tr><td align="left" rowspan="1" colspan="1">Recessive model</td><td colspan="2" align="center" rowspan="1">6&#x000b1;4.1</td><td align="left" rowspan="1" colspan="1">5.3&#x000b1;3.2</td><td align="left" rowspan="1" colspan="1">0.154&#x0002a;/NS</td><td colspan="2" align="center" rowspan="1">6&#x000b1;4.2</td><td align="left" rowspan="1" colspan="1">5.3&#x000b1;3.2</td><td align="left" rowspan="1" colspan="1"><bold>0.030</bold>&#x0002a;/0.24</td></tr><tr><td colspan="9" align="left" rowspan="1"><italic>2h FFA levels (mmol/l)</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">Equal weight</td><td align="left" rowspan="1" colspan="1">244&#x000b1;148</td><td align="left" rowspan="1" colspan="1">226&#x000b1;95</td><td align="left" rowspan="1" colspan="1">213&#x000b1;96</td><td align="left" rowspan="1" colspan="1"><bold>0.008</bold>/0.064</td><td align="left" rowspan="1" colspan="1">221&#x000b1;92</td><td align="left" rowspan="1" colspan="1">230&#x000b1;127</td><td align="left" rowspan="1" colspan="1">236&#x000b1;108</td><td align="left" rowspan="1" colspan="1">0.379/NS</td></tr><tr><td align="left" rowspan="1" colspan="1">Dominant model</td><td align="left" rowspan="1" colspan="1">244&#x000b1;148</td><td colspan="2" align="center" rowspan="1">223&#x000b1;95</td><td align="left" rowspan="1" colspan="1"><bold>0.010</bold>&#x0002a;/0.08</td><td align="left" rowspan="1" colspan="1">221&#x000b1;92</td><td colspan="2" align="center" rowspan="1">232&#x000b1;121</td><td align="left" rowspan="1" colspan="1">0.363&#x0002a;/NS</td></tr><tr><td align="left" rowspan="1" colspan="1">Recessive model</td><td colspan="2" align="center" rowspan="1">233&#x000b1;119</td><td align="left" rowspan="1" colspan="1">213&#x000b1;96</td><td align="left" rowspan="1" colspan="1"><bold>0.038</bold>&#x0002a;/0.304</td><td colspan="2" align="center" rowspan="1">227&#x000b1;118</td><td align="left" rowspan="1" colspan="1">236&#x000b1;108</td><td align="left" rowspan="1" colspan="1">0.519&#x0002a;/NS</td></tr></tbody></table><table-wrap-foot><fn id="nt106"><p>Legend to <xref ref-type="table" rid="pone-0001090-t004">Table 4</xref>. n&#x0200a;&#x0003d;&#x0200a;1011. Data are mean&#x000b1;SD. Asterisk (&#x0002a;) indicates results from linear regression analysis, adjusted for age, sex, BMI and family dependence. Both nominal and the Bonferroni-corrected p-values are shown. NS: not significant.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone-0001090-t005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0001090.t005</object-id><label>Table 5</label><caption><title>Insulinogenic index and post-OGTT FFA levels in rs1978013-rs1978014 haplotypes</title></caption><graphic id="pone-0001090-t005-5" xlink:href="pone.0001090.t005"/><table frame="hsides" rules="groups" alternate-form-of="pone-0001090-t005-5"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Haplotype</td><td align="left" rowspan="1" colspan="1">n</td><td align="left" rowspan="1" colspan="1">Insulinogenic index</td><td align="left" rowspan="1" colspan="1">score</td><td align="left" rowspan="1" colspan="1">p</td><td align="left" rowspan="1" colspan="1">Post-OGTT FFA level (mmol/l)</td><td align="left" rowspan="1" colspan="1">score</td><td align="left" rowspan="1" colspan="1">p</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">T-G</td><td align="left" rowspan="1" colspan="1">697</td><td align="left" rowspan="1" colspan="1">6.1&#x000b1;4.3</td><td align="left" rowspan="1" colspan="1">0.076</td><td align="left" rowspan="1" colspan="1">0.121/0.968</td><td align="left" rowspan="1" colspan="1">231&#x000b1;120</td><td align="left" rowspan="1" colspan="1">&#x02212;0.09</td><td align="left" rowspan="1" colspan="1"><bold>0.021</bold>/0.168</td></tr><tr><td align="left" rowspan="1" colspan="1">C-A</td><td align="left" rowspan="1" colspan="1">623</td><td align="left" rowspan="1" colspan="1">5.5&#x000b1;3.7</td><td align="left" rowspan="1" colspan="1">&#x02212;0.095</td><td align="left" rowspan="1" colspan="1"><bold>0.008</bold>/0.064</td><td align="left" rowspan="1" colspan="1">225&#x000b1;98</td><td align="left" rowspan="1" colspan="1">0.04</td><td align="left" rowspan="1" colspan="1">0.763/NS</td></tr><tr><td align="left" rowspan="1" colspan="1">T-A</td><td align="left" rowspan="1" colspan="1">459</td><td align="left" rowspan="1" colspan="1">6.0&#x000b1;3.9</td><td align="left" rowspan="1" colspan="1">0.022</td><td align="left" rowspan="1" colspan="1">0.987/NS</td><td align="left" rowspan="1" colspan="1">244&#x000b1;139</td><td align="left" rowspan="1" colspan="1">0.026</td><td align="left" rowspan="1" colspan="1">0.969/NS</td></tr><tr><td align="left" rowspan="1" colspan="1">C-G</td><td align="left" rowspan="1" colspan="1">241</td><td align="left" rowspan="1" colspan="1">5.8&#x000b1;3.8</td><td align="left" rowspan="1" colspan="1">&#x02212;0.006</td><td align="left" rowspan="1" colspan="1">1.000/NS</td><td align="left" rowspan="1" colspan="1">210&#x000b1;89</td><td align="left" rowspan="1" colspan="1">0.03</td><td align="left" rowspan="1" colspan="1">0.921/NS</td></tr></tbody></table><table-wrap-foot><fn id="nt107"><p>Legend to <xref ref-type="table" rid="pone-0001090-t005">Table 5</xref>. n&#x0200a;&#x0003d;&#x0200a;1011. Data are mean&#x000b1;SD. Scores of the linear regression analysis are reported. Both nominal and the Bonferroni-corrected p-values are shown. NS: not significant.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s4"><title>Discussion</title><p>The key finding of the present study was that rs1978013 and rs1978014 polymorphisms located upstream of the coding region of the <italic>FFAR1</italic> gene were associated with beta cell function in males and females respectively, however, due to the loss of statistical significance during Bonferroni corrections&#x02013;not in the whole sample. Carriers of the CC genotype of rs1978013 had the lowest insulinogenic index and highest risk of T2D (although not significant after Bonferroni correction) but rs1978014 associates with T2D according to chi<sup>2</sup> test. Increased T2D risk was discovered in the C-A haplotype carriers of SNPs rs1978013 and rs1978014.</p><p>The different association between the two polymorphisms in the <italic>FFAR1</italic> gene and insulin secretion in males and females might suggest that these polymorphisms may affect insulin sensitivity in a sex-specific manner in accordance with the finding of Hevener et al. showing that female rats are protected from lipid-induced reductions in insulin action <xref ref-type="bibr" rid="pone.0001090-Hevener1">&#x0005b;33&#x0005d;</xref>. We therefore tested this hypothesis by performing gender-specfic analyses of the putative effect of these SNPs on insulin sensitivity (HOMA). There was no association between HOMA and these polymorphisms, neither in the whole cohort nor after stratification for sex (data not shown). Correlation between HOMA and post-OGTT FFA level was also very weak (males: r<sup>2</sup>&#x0200a;&#x0003d;&#x0200a;0.17, p&#x0200a;&#x0003d;&#x0200a;0.0002, females: r<sup>2</sup>&#x0200a;&#x0003d;&#x0200a;0.20, p&#x0200a;&#x0003d;&#x0200a;0). This indicates that sex-specific differences in insulin sensitivity did not influence our results.</p><p>Although close to each other, rs1978013 and rs1978014 did not show any LD. This could possibly be explained by a recombination hot spot in this particular gene region. However, rs1978013 and rs1978014 captured the other common polymorphisms in the sequenced DNA region according to D' (<xref ref-type="supplementary-material" rid="pone.0001090.s002">Figure S2</xref>) at a low r<sup>2</sup> threshold 0.1&#x02013;0.3. In addition to association with T2D in the initial screening panel, lack of LD between the two neighbouring SNPs made these very close nucleotide positions of particular biological interest. The findings rather suggested that both SNPs, rs1978013 and rs1978014, together formed a haplotype, which increased risk of T2D.</p><p>FFAR1 was recently described as a cell-surface bound receptor for FFAs making it a candidate to mediate the negative effects of FFAs on beta cell function (lipotoxicity) <xref ref-type="bibr" rid="pone.0001090-Itoh1">&#x0005b;8&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0001090-Briscoe1">&#x0005b;10&#x0005d;</xref>. However, two recent studies did not find an association between variations in the <italic>FFAR1</italic> coding region and the risk of developing T2D <xref ref-type="bibr" rid="pone.0001090-Ogawa1">&#x0005b;34&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001090-Hamid1">&#x0005b;35&#x0005d;</xref>. Despite the lack of an association with T2D, Ogawa <italic>et al</italic>. found that the Arg211His polymorphism (rs2301151) in the coding region of <italic>FFAR1</italic> influenced serum insulin levels in 327 healthy Japanese males <xref ref-type="bibr" rid="pone.0001090-Ogawa1">&#x0005b;34&#x0005d;</xref>. Although this polymorphism is in LD with rs1978013 and rs1978014 according to D'&#x0200a;&#x0003d;&#x0200a;1, however the r<sup>2</sup> is low (0.08 for rs1978013 and 0.12 for rs1978014) (<xref ref-type="supplementary-material" rid="pone.0001090.s002">Figure S2</xref>) suggesting an independent association of these two SNPs with insulin secretion.</p><p>We have also analysed whether any SNPs in the recent whole genome association study <xref ref-type="bibr" rid="pone.0001090-Saxena1">&#x0005b;36&#x0005d;</xref> would cover the <italic>FFAR1</italic> gene. Unfortunately this region was not covered by any informative SNPs on the Affymetrix chip. The 19q13 chromosomal region where <italic>FFAR1</italic> is situated has shown linkage with T2D as well as T2D and lipid-related phenotypes <xref ref-type="bibr" rid="pone.0001090-2">&#x0005b;11&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001090-Malhotra1">&#x0005b;37&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0001090-Elbein1">&#x0005b;40&#x0005d;</xref>. However, we can only speculate whether the linkage could be attributed to <italic>FFAR1</italic> since the density of markers used in those studies is not high enough (approximate interval 7&#x02013;13 cM) to pinpoint <italic>FFAR1</italic> gene as a strong candidate for the reported linkage.</p><p>Little is known about the promoter structure and transcription factor binding sites of the <italic>FFAR1</italic> gene. <italic>FFAR1</italic> lacks a canonical TATA box, consistent with reports of other TATA-less G protein-coupled receptors <xref ref-type="bibr" rid="pone.0001090-LankatButtgereit1">&#x0005b;41&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001090-Svoboda1">&#x0005b;42&#x0005d;</xref>. The rs1978013 and rs1978014 polymorphisms apparently do not directly affect any potential transcription factor-binding motif. However, by sequence analysis, we identified three potential binding motifs for transcription factors which could be implicated in T2D development or beta cell function&#x02013;ATF6 <xref ref-type="bibr" rid="pone.0001090-Chu1">&#x0005b;43&#x0005d;</xref>, INSM1 <xref ref-type="bibr" rid="pone.0001090-Gierl1">&#x0005b;44&#x0005d;</xref> and NF-kappaB <xref ref-type="bibr" rid="pone.0001090-Ho1">&#x0005b;45&#x0005d;</xref> in close vicinity to rs1978013 and rs1978014. We can therefore not exclude the possibility that polymorphisms in the rs1978013 and rs1978014 might affect FFAR1 expression by altering transcription or they might be in linkage disequilibrium with another polymorphism affecting FFAR1 expression or function. Recently, Tomita et al. reported that insulinogenic index positively correlated with the <italic>FFAR1</italic> mRNA level in human pancreatic islets <xref ref-type="bibr" rid="pone.0001090-Tomita1">&#x0005b;46&#x0005d;</xref>, however, whether variations in the <italic>FFAR1</italic> gene induce up- or down regulation of gene expression remains unknown. Identification of regulatory region and subsequent functional studies are necessary to understand the hypothetical effect of rs1978013 and rs1978014 variants on FFAR1 expression levels.</p><p>In summary, our study suggests an effect of polymorphisms in the FFAR1 gene on insulin secretion during an OGTT thereby making it a potential candidate to mediate lipotoxicicty in T2D.</p></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0001090.s001"><label>Figure S1</label><caption><p>The sequenced region with the detected SNP positions. A 2379 bp long DNA sequence including the 903 bp of the coding region (underlined) in the FFAR1. Five SNPs (framed-rs1978013, rs1978014, rs10418569, rs2301151 and rs1573611) were registered in the NCBI database before, whereas eight (highlited) were not. The rs1978013 and rs1978014 SNPs are located at position 208 and 209, respectively.</p><p>(0.06 MB TIF)</p></caption><media xlink:href="pone.0001090.s001.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0001090.s002"><label>Figure S2</label><caption><p>LD structure of the sequenced FFAR1 region. SNPs are numbered according to their position in the sequenced region, nucleotide position 208 and 209 correspond to rs1978013 and rs1978014, respectively, and positions 592, 1437 and 2059-to rs10418569, rs2301151 (Arg211His) and rs1573611, respectively.</p><p>(0.94 MB TIF)</p></caption><media xlink:href="pone.0001090.s002.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0001090.s003"><label>Table S1</label><caption><p>Sex-specific genotype frequencies and odds ratios of the rs1978013. Logistic regression results are adjusted for age, sex, BMI and family dependence. Both nominal and the Bonferroni-corrected p-values are shown. NS: not significant.</p><p>(0.04 MB DOC)</p></caption><media xlink:href="pone.0001090.s003.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0001090.s004"><label>Table S2</label><caption><p>Insulinogenic index and post-OGTT FFA levels in different genotype carriers stratified for sex. Males: n&#x0200a;&#x0003d;&#x0200a;475, females: n&#x0200a;&#x0003d;&#x0200a;536. Data are mean&#x000b1;SD. Asterisk (&#x0002a;) indicates results from linear regression analysis, adjusted for age, BMI and family dependence. Both nominal and the Bonferroni-corrected p-values are shown. NS: not significant.</p><p>(0.05 MB DOC)</p></caption><media xlink:href="pone.0001090.s004.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We thank Johan Holmkvist, Marketa Sj&#x000f6;gren, Margareta Svensson, Anna Berglund, Nael Shaat and Hemang Parikh for support and technical help, Holger Luthman, Bj&#x000f6;rn Olde and Christer Owman for valuable discussions and suggestions and the SWEGENE Profiling Polygenic Disease facility for the possibility to use the ABI Prism 3730 genetic analyser.</p></ack><ref-list><title>References</title><ref id="pone.0001090-Groop1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Groop</surname><given-names>L</given-names></name></person-group><year>2000</year><article-title>Pathogenesis of type 2 diabetes: the relative contribution of insulin resistance and impaired insulin secretion.</article-title><source>Int J Clin Pract</source><issue>Suppl</issue><fpage>3</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">10750249</pub-id></citation></ref><ref id="pone.0001090-LeRoith1"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>LeRoith</surname><given-names>D</given-names></name></person-group><year>2002</year><article-title>Beta-cell dysfunction and insulin resistance in type 2 diabetes: role of metabolic and genetic abnormalities.</article-title><source>Am J Med</source><volume>113</volume><issue>Suppl 6A</issue><fpage>3S</fpage><lpage>11S</lpage><pub-id pub-id-type="pmid">12431757</pub-id></citation></ref><ref id="pone.0001090-1"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Del Prato</surname><given-names>S</given-names></name><name><surname>Marchetti</surname><given-names>P</given-names></name></person-group><year>2004</year><article-title>Beta- and alpha-cell dysfunction in type 2 diabetes.</article-title><source>Horm Metab Res</source><volume>36</volume><fpage>775</fpage><lpage>781</lpage><pub-id pub-id-type="pmid">15655708</pub-id></citation></ref><ref id="pone.0001090-Ahren1"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ahren</surname><given-names>B</given-names></name></person-group><year>2005</year><article-title>Type 2 diabetes, insulin secretion and beta-cell mass.</article-title><source>Curr Mol Med</source><volume>5</volume><fpage>275</fpage><lpage>286</lpage><pub-id pub-id-type="pmid">15892647</pub-id></citation></ref><ref id="pone.0001090-Manco1"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Manco</surname><given-names>M</given-names></name><name><surname>Calvani</surname><given-names>M</given-names></name><name><surname>Mingrone</surname><given-names>G</given-names></name></person-group><year>2004</year><article-title>Effects of dietary fatty acids on insulin sensitivity and secretion.</article-title><source>Diabetes Obes Metab</source><volume>6</volume><fpage>402</fpage><lpage>413</lpage><pub-id pub-id-type="pmid">15479216</pub-id></citation></ref><ref id="pone.0001090-Steppel1"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Steppel</surname><given-names>JH</given-names></name><name><surname>Horton</surname><given-names>ES</given-names></name></person-group><year>2004</year><article-title>Beta-cell failure in the pathogenesis of type 2 diabetes mellitus.</article-title><source>Curr Diab Rep</source><volume>4</volume><fpage>169</fpage><lpage>175</lpage><pub-id pub-id-type="pmid">15132880</pub-id></citation></ref><ref id="pone.0001090-Robertson1"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Robertson</surname><given-names>RP</given-names></name><name><surname>Harmon</surname><given-names>J</given-names></name><name><surname>Tran</surname><given-names>PO</given-names></name><name><surname>Poitout</surname><given-names>V</given-names></name></person-group><year>2004</year><article-title>Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes.</article-title><source>Diabetes</source><volume>53</volume><issue>Suppl 1</issue><fpage>S119</fpage><lpage>124</lpage><pub-id pub-id-type="pmid">14749276</pub-id></citation></ref><ref id="pone.0001090-Itoh1"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Itoh</surname><given-names>Y</given-names></name><name><surname>Kawamata</surname><given-names>Y</given-names></name><name><surname>Harada</surname><given-names>M</given-names></name><name><surname>Kobayashi</surname><given-names>M</given-names></name><name><surname>Fujii</surname><given-names>R</given-names></name><etal/></person-group><year>2003</year><article-title>Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40.</article-title><source>Nature</source><volume>422</volume><fpage>173</fpage><lpage>176</lpage><pub-id pub-id-type="pmid">12629551</pub-id></citation></ref><ref id="pone.0001090-Kotarsky1"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kotarsky</surname><given-names>K</given-names></name><name><surname>Nilsson</surname><given-names>NE</given-names></name><name><surname>Flodgren</surname><given-names>E</given-names></name><name><surname>Owman</surname><given-names>C</given-names></name><name><surname>Olde</surname><given-names>B</given-names></name></person-group><year>2003</year><article-title>A human cell surface receptor activated by free fatty acids and thiazolidinedione drugs.</article-title><source>Biochem Biophys Res Commun</source><volume>301</volume><fpage>406</fpage><lpage>410</lpage><pub-id pub-id-type="pmid">12565875</pub-id></citation></ref><ref id="pone.0001090-Briscoe1"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Briscoe</surname><given-names>CP</given-names></name><name><surname>Tadayyon</surname><given-names>M</given-names></name><name><surname>Andrews</surname><given-names>JL</given-names></name><name><surname>Benson</surname><given-names>WG</given-names></name><name><surname>Chambers</surname><given-names>JK</given-names></name><etal/></person-group><year>2003</year><article-title>The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids.</article-title><source>J Biol Chem</source><volume>278</volume><fpage>11303</fpage><lpage>11311</lpage><pub-id pub-id-type="pmid">12496284</pub-id></citation></ref><ref id="pone.0001090-2"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Tilburg</surname><given-names>JH</given-names></name><name><surname>Sandkuijl</surname><given-names>LA</given-names></name><name><surname>Strengman</surname><given-names>E</given-names></name><name><surname>van Someren</surname><given-names>H</given-names></name><name><surname>Rigters-Aris</surname><given-names>CA</given-names></name><etal/></person-group><year>2003</year><article-title>A genome-wide scan in type 2 diabetes mellitus provides independent replication of a susceptibility locus on 18p11 and suggests the existence of novel Loci on 2q12 and 19q13.</article-title><source>J Clin Endocrinol Metab</source><volume>88</volume><fpage>2223</fpage><lpage>2230</lpage><pub-id pub-id-type="pmid">12727978</pub-id></citation></ref><ref id="pone.0001090-Mori1"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>Y</given-names></name><name><surname>Otabe</surname><given-names>S</given-names></name><name><surname>Dina</surname><given-names>C</given-names></name><name><surname>Yasuda</surname><given-names>K</given-names></name><name><surname>Populaire</surname><given-names>C</given-names></name><etal/></person-group><year>2002</year><article-title>Genome-wide search for type 2 diabetes in Japanese affected sib-pairs confirms susceptibility genes on 3q, 15q, and 20q and identifies two new candidate Loci on 7p and 11p.</article-title><source>Diabetes</source><volume>51</volume><fpage>1247</fpage><lpage>1255</lpage><pub-id pub-id-type="pmid">11916952</pub-id></citation></ref><ref id="pone.0001090-Panhuysen1"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Panhuysen</surname><given-names>CI</given-names></name><name><surname>Cupples</surname><given-names>LA</given-names></name><name><surname>Wilson</surname><given-names>PW</given-names></name><name><surname>Herbert</surname><given-names>AG</given-names></name><name><surname>Myers</surname><given-names>RH</given-names></name><etal/></person-group><year>2003</year><article-title>A genome scan for loci linked to quantitative insulin traits in persons without diabetes: the Framingham Offspring Study.</article-title><source>Diabetologia</source><volume>46</volume><fpage>579</fpage><lpage>587</lpage><pub-id pub-id-type="pmid">12739029</pub-id></citation></ref><ref id="pone.0001090-Sawzdargo1"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sawzdargo</surname><given-names>M</given-names></name><name><surname>George</surname><given-names>SR</given-names></name><name><surname>Nguyen</surname><given-names>T</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Kolakowski</surname><given-names>LF</given-names></name><etal/></person-group><year>1997</year><article-title>A cluster of four novel human G protein-coupled receptor genes occurring in close proximity to CD22 gene on chromosome 19q13.1.</article-title><source>Biochem Biophys Res Commun</source><volume>239</volume><fpage>543</fpage><lpage>547</lpage><pub-id pub-id-type="pmid">9344866</pub-id></citation></ref><ref id="pone.0001090-Latour1"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Latour</surname><given-names>MG</given-names></name><name><surname>Alquier</surname><given-names>T</given-names></name><name><surname>Oseid</surname><given-names>E</given-names></name><name><surname>Tremblay</surname><given-names>C</given-names></name><name><surname>Jetton</surname><given-names>TL</given-names></name><etal/></person-group><year>2007</year><article-title>GPR40 is necessary but not sufficient for fatty acid stimulation of insulin secretion in vivo.</article-title><source>Diabetes</source><volume>56</volume><fpage>1087</fpage><lpage>1094</lpage><pub-id pub-id-type="pmid">17395749</pub-id></citation></ref><ref id="pone.0001090-Steneberg1"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Steneberg</surname><given-names>P</given-names></name><name><surname>Rubins</surname><given-names>N</given-names></name><name><surname>Bartoov-Shifman</surname><given-names>R</given-names></name><name><surname>Walker</surname><given-names>MD</given-names></name><name><surname>Edlund</surname><given-names>H</given-names></name></person-group><year>2005</year><article-title>The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse.</article-title><source>Cell Metab</source><volume>1</volume><fpage>245</fpage><lpage>258</lpage><pub-id pub-id-type="pmid">16054069</pub-id></citation></ref><ref id="pone.0001090-Groop2"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Groop</surname><given-names>L</given-names></name><name><surname>Forsblom</surname><given-names>C</given-names></name><name><surname>Lehtovirta</surname><given-names>M</given-names></name><name><surname>Tuomi</surname><given-names>T</given-names></name><name><surname>Karanko</surname><given-names>S</given-names></name><etal/></person-group><year>1996</year><article-title>Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects.</article-title><source>Diabetes</source><volume>45</volume><fpage>1585</fpage><lpage>1593</lpage><pub-id pub-id-type="pmid">8866565</pub-id></citation></ref><ref id="pone.0001090-Alberti1"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alberti</surname><given-names>KG</given-names></name><name><surname>Zimmet</surname><given-names>PZ</given-names></name></person-group><year>1998</year><article-title>Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.</article-title><source>Diabet Med</source><volume>15</volume><fpage>539</fpage><lpage>553</lpage><pub-id pub-id-type="pmid">9686693</pub-id></citation></ref><ref id="pone.0001090-Matthews1"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matthews</surname><given-names>DR</given-names></name><name><surname>Hosker</surname><given-names>JP</given-names></name><name><surname>Rudenski</surname><given-names>AS</given-names></name><name><surname>Naylor</surname><given-names>BA</given-names></name><name><surname>Treacher</surname><given-names>DF</given-names></name><etal/></person-group><year>1985</year><article-title>Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.</article-title><source>Diabetologia</source><volume>28</volume><fpage>412</fpage><lpage>419</lpage><pub-id pub-id-type="pmid">3899825</pub-id></citation></ref><ref id="pone.0001090-National1"><label>20</label><citation citation-type="book"><collab>National Center for Biotechnology Information</collab><year>2007</year><article-title>NCBI.</article-title></citation></ref><ref id="pone.0001090-Daly1"><label>21</label><citation citation-type="book"><collab>Daly Lab at the Whitehead Institute, Cambridge, USA</collab><year>2007</year><article-title>Haploview.</article-title></citation></ref><ref id="pone.0001090-Barrett1"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>JC</given-names></name><name><surname>Fry</surname><given-names>B</given-names></name><name><surname>Maller</surname><given-names>J</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name></person-group><year>2005</year><article-title>Haploview: analysis and visualization of LD and haplotype maps.</article-title><source>Bioinformatics</source><volume>21</volume><fpage>263</fpage><lpage>265</lpage><pub-id pub-id-type="pmid">15297300</pub-id></citation></ref><ref id="pone.0001090-Eskin1"><label>23</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Eskin</surname><given-names>E</given-names></name><name><surname>Halperin</surname><given-names>E</given-names></name></person-group><year>2006</year><article-title>HAP haplotype analysis system.</article-title></citation></ref><ref id="pone.0001090-Halperin1"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Halperin</surname><given-names>E</given-names></name><name><surname>Eskin</surname><given-names>E</given-names></name></person-group><year>2004</year><article-title>Haplotype reconstruction from genotype data using Imperfect Phylogeny.</article-title><source>Bioinformatics</source><volume>20</volume><fpage>1842</fpage><lpage>1849</lpage><pub-id pub-id-type="pmid">14988101</pub-id></citation></ref><ref id="pone.0001090-Purcell1"><label>25</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Purcell</surname><given-names>S</given-names></name><name><surname>Sham</surname><given-names>P</given-names></name></person-group><year>2003</year><article-title>Genetic Power Calculator.</article-title></citation></ref><ref id="pone.0001090-Purcell2"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Purcell</surname><given-names>S</given-names></name><name><surname>Cherny</surname><given-names>SS</given-names></name><name><surname>Sham</surname><given-names>PC</given-names></name></person-group><year>2003</year><article-title>Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits.</article-title><source>Bioinformatics</source><volume>19</volume><fpage>149</fpage><lpage>150</lpage><pub-id pub-id-type="pmid">12499305</pub-id></citation></ref><ref id="pone.0001090-Itoh2"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Itoh</surname><given-names>Y</given-names></name><name><surname>Hinuma</surname><given-names>S</given-names></name></person-group><year>2005</year><article-title>GPR40, a free fatty acid receptor on pancreatic beta cells, regulates insulin secretion.</article-title><source>Hepatol Res</source><volume>33</volume><fpage>171</fpage><lpage>173</lpage><pub-id pub-id-type="pmid">16214394</pub-id></citation></ref><ref id="pone.0001090-Jachez1"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jachez</surname><given-names>B</given-names></name><name><surname>Montecino-Rodriguez</surname><given-names>E</given-names></name><name><surname>Fonteneau</surname><given-names>P</given-names></name><name><surname>Loor</surname><given-names>F</given-names></name></person-group><year>1988</year><article-title>Partial expression of the lpr locus in the heterozygous state: presence of autoantibodies.</article-title><source>Immunology</source><volume>64</volume><fpage>31</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">3260217</pub-id></citation></ref><ref id="pone.0001090-Hawkins1"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hawkins</surname><given-names>RK</given-names></name><name><surname>Jansen</surname><given-names>HG</given-names></name><name><surname>Sanyal</surname><given-names>S</given-names></name></person-group><year>1985</year><article-title>Development and degeneration of retina in rds mutant mice: photoreceptor abnormalities in the heterozygotes.</article-title><source>Exp Eye Res</source><volume>41</volume><fpage>701</fpage><lpage>720</lpage><pub-id pub-id-type="pmid">3830736</pub-id></citation></ref><ref id="pone.0001090-Genomatix1"><label>30</label><citation citation-type="book"><collab>Genomatix, Munich, Germany</collab><year>2007</year><article-title>MatInspector.</article-title></citation></ref><ref id="pone.0001090-Cartharius1"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cartharius</surname><given-names>K</given-names></name><name><surname>Frech</surname><given-names>K</given-names></name><name><surname>Grote</surname><given-names>K</given-names></name><name><surname>Klocke</surname><given-names>B</given-names></name><name><surname>Haltmeier</surname><given-names>M</given-names></name><etal/></person-group><year>2005</year><article-title>MatInspector and beyond: promoter analysis based on transcription factor binding sites.</article-title><source>Bioinformatics</source><volume>21</volume><fpage>2933</fpage><lpage>2942</lpage><pub-id pub-id-type="pmid">15860560</pub-id></citation></ref><ref id="pone.0001090-3"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Bakker</surname><given-names>PI</given-names></name><name><surname>Yelensky</surname><given-names>R</given-names></name><name><surname>Pe'er</surname><given-names>I</given-names></name><name><surname>Gabriel</surname><given-names>SB</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><etal/></person-group><year>2005</year><article-title>Efficiency and power in genetic association studies.</article-title><source>Nat Genet</source><volume>37</volume><fpage>1217</fpage><lpage>1223</lpage><pub-id pub-id-type="pmid">16244653</pub-id></citation></ref><ref id="pone.0001090-Hevener1"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hevener</surname><given-names>A</given-names></name><name><surname>Reichart</surname><given-names>D</given-names></name><name><surname>Janez</surname><given-names>A</given-names></name><name><surname>Olefsky</surname><given-names>J</given-names></name></person-group><year>2002</year><article-title>Female rats do not exhibit free fatty acid-induced insulin resistance.</article-title><source>Diabetes</source><volume>51</volume><fpage>1907</fpage><lpage>1912</lpage><pub-id pub-id-type="pmid">12031980</pub-id></citation></ref><ref id="pone.0001090-Ogawa1"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ogawa</surname><given-names>T</given-names></name><name><surname>Hirose</surname><given-names>H</given-names></name><name><surname>Miyashita</surname><given-names>K</given-names></name><name><surname>Saito</surname><given-names>I</given-names></name><name><surname>Saruta</surname><given-names>T</given-names></name></person-group><year>2005</year><article-title>GPR40 gene Arg211His polymorphism may contribute to the variation of insulin secretory capacity in Japanese men.</article-title><source>Metabolism</source><volume>54</volume><fpage>296</fpage><lpage>299</lpage><pub-id pub-id-type="pmid">15736105</pub-id></citation></ref><ref id="pone.0001090-Hamid1"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hamid</surname><given-names>YH</given-names></name><name><surname>Vissing</surname><given-names>H</given-names></name><name><surname>Holst</surname><given-names>B</given-names></name><name><surname>Urhammer</surname><given-names>SA</given-names></name><name><surname>Pyke</surname><given-names>C</given-names></name><etal/></person-group><year>2005</year><article-title>Studies of relationships between variation of the human G protein-coupled receptor 40 Gene and Type 2 diabetes and insulin release.</article-title><source>Diabet Med</source><volume>22</volume><fpage>74</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">15606695</pub-id></citation></ref><ref id="pone.0001090-Saxena1"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saxena</surname><given-names>R</given-names></name><name><surname>Voight</surname><given-names>BF</given-names></name><name><surname>Lyssenko</surname><given-names>V</given-names></name><name><surname>Burtt</surname><given-names>NP</given-names></name><name><surname>de Bakker</surname><given-names>PI</given-names></name><etal/></person-group><year>2007</year><article-title>Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.</article-title><source>Science</source><volume>316</volume><fpage>1331</fpage><lpage>1336</lpage><pub-id pub-id-type="pmid">17463246</pub-id></citation></ref><ref id="pone.0001090-Malhotra1"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Malhotra</surname><given-names>A</given-names></name><name><surname>Elbein</surname><given-names>SC</given-names></name><name><surname>Ng</surname><given-names>MC</given-names></name><name><surname>Duggirala</surname><given-names>R</given-names></name><name><surname>Arya</surname><given-names>R</given-names></name><etal/></person-group><year>2007</year><article-title>Meta-analysis of genome-wide linkage studies of quantitative lipid traits in families ascertained for type 2 diabetes.</article-title><source>Diabetes</source><volume>56</volume><fpage>890</fpage><lpage>896</lpage><pub-id pub-id-type="pmid">17327462</pub-id></citation></ref><ref id="pone.0001090-An1"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>An</surname><given-names>P</given-names></name><name><surname>Freedman</surname><given-names>BI</given-names></name><name><surname>Hanis</surname><given-names>CL</given-names></name><name><surname>Chen</surname><given-names>YD</given-names></name><name><surname>Weder</surname><given-names>AB</given-names></name><etal/></person-group><year>2005</year><article-title>Genome-wide linkage scans for fasting glucose, insulin, and insulin resistance in the National Heart, Lung, and Blood Institute Family Blood Pressure Program: evidence of linkages to chromosome 7q36 and 19q13 from meta-analysis.</article-title><source>Diabetes</source><volume>54</volume><fpage>909</fpage><lpage>914</lpage><pub-id pub-id-type="pmid">15734873</pub-id></citation></ref><ref id="pone.0001090-Guo1"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>YF</given-names></name><name><surname>Shen</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>YJ</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Xiong</surname><given-names>DH</given-names></name><etal/></person-group><year>2006</year><article-title>Assessment of genetic linkage and parent-of-origin effects on obesity.</article-title><source>J Clin Endocrinol Metab</source><volume>91</volume><fpage>4001</fpage><lpage>4005</lpage><pub-id pub-id-type="pmid">16835282</pub-id></citation></ref><ref id="pone.0001090-Elbein1"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Elbein</surname><given-names>SC</given-names></name><name><surname>Hasstedt</surname><given-names>SJ</given-names></name></person-group><year>2002</year><article-title>Quantitative trait linkage analysis of lipid-related traits in familial type 2 diabetes: evidence for linkage of triglyceride levels to chromosome 19q.</article-title><source>Diabetes</source><volume>51</volume><fpage>528</fpage><lpage>535</lpage><pub-id pub-id-type="pmid">11812765</pub-id></citation></ref><ref id="pone.0001090-LankatButtgereit1"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lankat-Buttgereit</surname><given-names>B</given-names></name><name><surname>Goke</surname><given-names>B</given-names></name></person-group><year>1997</year><article-title>Cloning and characterization of the 5&#x02032; flanking sequences (promoter region) of the human GLP-1 receptor gene.</article-title><source>Peptides</source><volume>18</volume><fpage>617</fpage><lpage>624</lpage><pub-id pub-id-type="pmid">9213353</pub-id></citation></ref><ref id="pone.0001090-Svoboda1"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Svoboda</surname><given-names>M</given-names></name><name><surname>Portois</surname><given-names>L</given-names></name><name><surname>Malaisse</surname><given-names>WJ</given-names></name></person-group><year>1999</year><article-title>Glucose regulation of the expression of the glucagon receptor gene.</article-title><source>Mol Genet Metab</source><volume>68</volume><fpage>258</fpage><lpage>267</lpage><pub-id pub-id-type="pmid">10527677</pub-id></citation></ref><ref id="pone.0001090-Chu1"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>WS</given-names></name><name><surname>Das</surname><given-names>SK</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Chan</surname><given-names>JC</given-names></name><name><surname>Deloukas</surname><given-names>P</given-names></name><etal/></person-group><year>2007</year><article-title>Activating transcription factor 6 (ATF6) sequence polymorphisms in type 2 diabetes and pre-diabetic traits.</article-title><source>Diabetes</source><volume>56</volume><fpage>856</fpage><lpage>862</lpage><pub-id pub-id-type="pmid">17327457</pub-id></citation></ref><ref id="pone.0001090-Gierl1"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gierl</surname><given-names>MS</given-names></name><name><surname>Karoulias</surname><given-names>N</given-names></name><name><surname>Wende</surname><given-names>H</given-names></name><name><surname>Strehle</surname><given-names>M</given-names></name><name><surname>Birchmeier</surname><given-names>C</given-names></name></person-group><year>2006</year><article-title>The zinc-finger factor Insm1 (IA-1) is essential for the development of pancreatic beta cells and intestinal endocrine cells.</article-title><source>Genes Dev</source><volume>20</volume><fpage>2465</fpage><lpage>2478</lpage><pub-id pub-id-type="pmid">16951258</pub-id></citation></ref><ref id="pone.0001090-Ho1"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>E</given-names></name><name><surname>Bray</surname><given-names>TM</given-names></name></person-group><year>1999</year><article-title>Antioxidants, NFkappaB activation, and diabetogenesis.</article-title><source>Proc Soc Exp Biol Med</source><volume>222</volume><fpage>205</fpage><lpage>213</lpage><pub-id pub-id-type="pmid">10601879</pub-id></citation></ref><ref id="pone.0001090-Tomita1"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tomita</surname><given-names>T</given-names></name><name><surname>Masuzaki</surname><given-names>H</given-names></name><name><surname>Iwakura</surname><given-names>H</given-names></name><name><surname>Fujikura</surname><given-names>J</given-names></name><name><surname>Noguchi</surname><given-names>M</given-names></name><etal/></person-group><year>2006</year><article-title>Expression of the gene for a membrane-bound fatty acid receptor in the pancreas and islet cell tumours in humans: evidence for GPR40 expression in pancreatic beta cells and implications for insulin secretion.</article-title><source>Diabetologia</source></citation></ref></ref-list><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>This study was supported by UMAS Foundations, Diabetes Program at Lund University, Albert P&#x000e5;hlssons Foundation, Swedish Research Council, Sigrid Juselius Foundation, Folkhalsan Research Foundation and Swedish Diabetes Research Foundation. CMC is supported by Juvenile Diabetes Research Foundation (Grant 11-2004-38).</p></fn></fn-group></back></article> 